Literature DB >> 22665299

A rapid approach for isobaric peptide termini labeling.

Christian J Koehler1, Magnus O Arntzen, Achim Treumann, Bernd Thiede.   

Abstract

Isobaric peptide termini labeling (IPTL) is a recently introduced approach to the chemical labeling of peptides with isotopic reagents. Peptides derived from two different samples are labeled at the N terminus and at the C terminus with isotopically labeled reagents that have identical mass differences. To obtain isobaric peptides, labeling is carried out such that the introduced mass increase at one terminus will exactly match the mass decrease at the other terminus (and the other way around). This results in product ion spectra that display the quantitative difference of the peptide signal derived from the two samples for every b-ion and y-ion in the spectrum. The original IPTL approach required the selective modification of lysines followed by C-18 micropurification of modified peptides and reaction of the N termini. Here, we describe a new approach for IPTL that is based on the selective modification of the peptide N termini with succinic anhydride and subsequent reductive amination of C-terminal lysines with formaldehyde and cyanoborohydride. Both reactions can be carried out in one pot within 10 min and without C-18 micropurification. In addition, we present the software package IsobariQ for straightforward data analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665299     DOI: 10.1007/978-1-61779-885-6_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

2.  Interference-free proteome quantification with MS/MS-based isobaric isotopologue detection.

Authors:  Casimir Bamberger; Sandra Pankow; Sung Kyu Robin Park; John R Yates
Journal:  J Proteome Res       Date:  2014-02-11       Impact factor: 4.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.